跳至主要内容
临床试验/NCT04512443
NCT04512443已完成不适用

Clinical Efficacy of Conservative Treatment in Female Patients With Plevic Congestion Syndrome

Interregional Clinical Diagnostic Center, Russia2 个研究点 分布在 1 个国家目标入组 83 人开始时间: 2019年12月28日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
83
试验地点
2
主要终点
Pelvic Varicose Veins Questionnaire

研究概览

简要总结

The article presents the results of a randomized, placebo-controlled study of the conservative treatment with Daflon (Detralex) in female patients with Pelvic congestion syndrome .

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • The presence of pelvic varicose veins verified by transvaginal and transabdominal duplex ultrasound scanning

排除标准

  • Severe disease of the gastrointestinal tract or hematopoietic system
  • Terminal stage of cardiovascular, respiratory, renal or hepatic failure
  • Grade IV malignancy
  • Peripheral artery disease (PAD) of the lower extremities, any type of diabetes, or mental disease.
  • Pregnant women at any gestational age, women who gave birth less than 12 months ago, and breastfeeding mothers.

研究组 & 干预措施

1

42 women (treated with Daflon 1000 mg (study group))

干预措施: Daflon (Drug)

结局指标

主要结局

Pelvic Varicose Veins Questionnaire

时间窗: 2 months

Assessment of quality of life according to the questionnaire before and after treatment

次要结局

未报告次要终点

研究者

发起方
Interregional Clinical Diagnostic Center, Russia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Akhmetzianov Rustem

Principal Investigator

Interregional Clinical Diagnostic Center, Russia

研究点 (2)

Loading locations...

相似试验

Clinical Efficacy of Conservative Treatment in... | 临床试验